Mkts

Zevra Therapeutics, Inc.

NASDAQ: ZVRA
$10.16+0.22 (+2.21%)
As of Oct 19, 4:00 PM ET

Key statistics

Day range
9.8410.20
52-week range
8.0115.04
Today
Open9.94
Previous close10.16
Volume936.3K
Valuation
Market cap613.42M
P/E ratio10.53×
EPS (TTM)0.97
Income & risk
Dividend / yield—
Beta0.98
Avg volume1.21M
Discussion

ZVRA News

Stories mentioning ZVRA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development
Sales General & Admin20,78320,35416,93520,78219,54516,12516,20812,604
Total Operating Expenses
Operating Income (Loss)52,1469,3154,143(71,039)(5,362)(15,416)(27,306)(23,795)
Interest Income
Interest Expense
Other Expense
Pretax Income44,80412,666(977.00)76,906(1,917)(20,368)(33,225)(19,855)
Tax Provision6,914501.00(433.00)2,1991,18215,3710.0070.00
Net Income (Loss)37,89012,165(544.00)74,707(3,099)(35,739)(33,225)(19,925)
Earnings Per Share (Basic)0.620.22(0.01)1.24(0.06)(0.77)(0.69)(0.48)
Earnings Per Share (Diluted)0.600.21(0.01)1.21(0.06)(0.69)(0.48)
Weighted Average Shares Outstanding (Basic)58,40655,31155,95254,78154,09646,25147,80941,899
Weighted Average Shares Outstanding (Diluted)60,23057,26355,95256,32554,09647,80941,899

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ZVRA

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is a stock listed on the Nasdaq Stock Market under the ticker symbol ZVRA. It last traded at $10.16 (Oct 19, 2026, 4:00 PM ET), up 2.2% on the day. That gives Zevra Therapeutics a market capitalisation of $613.4M and a price-to-earnings ratio of 10.5.

Over the past 52 weeks ZVRA has traded between $8.01 and $15.04.

Net income for the quarter ended Mar 31, 2026 was $37.9M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—$37.9M
Dec 31, 2025—$12.2M
Sep 30, 2025—-$544.0K
Jun 30, 2025—$74.7M

From Zevra Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…